Decoy Therapeutics Inc. (DCOY) Live Share Price, Invest From India

Decoy Therapeutics Inc. Stock Performance

as on July 18, 2026 at 2:15 pm IST

Day's Low
Day's High
$5.49
Day's Price Range
$6.06
$5.61
2.14%
Downside
8.02%
Upside
52 Week's Low
52 Week's High
52-Week Price Range
$5.61
100.00%
Downside
-100.00%
Upside

Decoy Therapeutics Inc. share price movements today

Previous Close: $5.99
Open: $5.79
Volume: 231.9K
Day's Low - High: $5.49 - $6.06

Decoy Therapeutics Inc. Historical Returns

1 Month Return: -7.58 %
3 Month Return: -3.44 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Decoy Therapeutics Inc. Stock Fundamentals & Key Indicators

Check Decoy Therapeutics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$3.1M

EPS (TTM)

-12.96

Dividend Yield

0.00%

PE Ratio (TTM)

0.05

Industry PE ratio

-2.8405109489051097

PEG Ratio

Return On Equity TTM

-661.73%

Decoy Therapeutics Inc. Stock Valuation

Track how Decoy Therapeutics Inc. P/E has moved over time to understand its valuation trends.

Decoy Therapeutics Inc. in the last 5 years

Overview
Trends

Lowest (0.52x)

March 31, 2026

Industry (-2.84x)

July 18, 2026

Today (0.05x)

July 18, 2026

Highest (0.52x)

March 31, 2026

LowHigh

Today’s Price to Earnings Ratio: 0.05x

Decoy Therapeutics Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Decoy Therapeutics Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Decoy Therapeutics Inc.	NA	$3.1M	NA	0.05	0.00%	NA
Revolution Medicines Inc.	BUY	$38.1B	524.49%	NA	0.00%	NA
Vertex Pharmaceuticals Inc.	BUY	$123.4B	140.09%	28.32	35.51%	NA
Regeneron Pharmaceuticals Inc.	BUY	$71.2B	16.02%	16.23	29.65%	0.54%

Indian Investors' Interest in Decoy Therapeutics Inc. Stock

Search interest for Decoy Therapeutics Inc. Stock has increased by 1059% in the last 30 days, reflecting an upward trend in search activity.

Time period: June 18, 2026 to July 18, 2026

Change:1059% versus previous 30 day period

Decoy Therapeutics Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	-	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	-8	-
Operating Income	-1	-1	-1	0	0	-9	-2
EBITDA	0	-1	-1	0	0	-8	-2
Interest Expense	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0
Income Before Tax	0	-1	-1	0	0	-8	-2
Income Tax Expense	-	-	-	-	-	-	-
Net Income	0	-1	-1	0	0	-8	-2
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Decoy Therapeutics Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	1	1	0	3	5	1	-	-	-	-
Gross Profit	0	0	0	3	5	1	0	0	0	-8
Operating Income	-39	-34	-22	-8	-7	-12	-31	-12	-5	-12
EBITDA	-39	-34	-21	-8	-7	-12	-22	-12	-5	-12
Interest Expense	-	-	-	-	0	-	-	-	-	-
Depreciation	-	-	-	-	-	0	0	0	0	0
Income Before Tax	-39	-34	-21	-6	-7	-12	-31	-12	-5	-12
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-39	-34	-21	-6	-7	-12	-31	-12	-5	-12
Net Profit Margin	-3907.65%	-2701.74%	-2615.57%	-200.18%	-140.49%	-693.84%	0.00%	0.00%	0.00%	0.00%

Decoy Therapeutics Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-1	-1	0	-1	-1	0	0	-8	-2
Operating Cash Flow	-1	-1	-1	0	-1	0	-1	-1	-2
Investing Cash Flow	-	-	-	-	-	-	0	0	-
Financing Cash Flow	0	0	1	0	0	0	5	6	-
Change in Cash	-1	-1	0	0	0	-1	4	5	-2

Decoy Therapeutics Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-34	-21	-6	-7	-12	-31	-12	-5	-12
Operating Cash Flow	-27	-23	-11	-10	-10	-17	-12	-4	-4
Investing Cash Flow	24	14	5	0	-	-1	-	-	0
Financing Cash Flow	0	0	3	17	28	1	6	1	12
Change in Cash	-3	-9	-2	7	18	-17	-6	-3	8

Global Institutional Holdings in Decoy Therapeutics Inc.

Funds	Holdings
UBS Group AG	0.1%
Morgan Stanley - Brokerage Accounts	0%
Danske Bank A/S.	0%
XTX Topco Ltd	0%
Tower Research Capital LLC	0.19%

See all

Insights on Decoy Therapeutics Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Revolution Medicines, Inc. Common Stock has given 386.1% return, outperforming this stock by 425.3%
NO EFFECT
Against Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 593.9% return, outperforming this stock by 689.7%
NEGATIVE IMPACT
Price Dip
In the last 3 years, DCOY stock has moved down by -95.8%

About Decoy Therapeutics Inc.

Decoy Therapeutics Inc. operates as a pre-clinical stage biotechnology company. It focuses on advancing the peptide conjugate therapeutics through its Immediate Peptide/PPMO/P-PROTAC Alpha-helical Conjugate Technology (IMP3ACT) platform that leverages peptide coiled-coils chemistry and physics to design a-helical peptides through computational and ML tools. The company's IMP3ACT platform leverages machine learning and artificial intelligence tools alongside synthesis techniques to engineer, enhance, and manufacture peptide conjugates targeting various unmet medical needs. It focuses on building a portfolio of peptide conjugate therapeutics focusing on infectious diseases and oncology. The company was formerly known as Salarius Pharmaceuticals, Inc. and change its name to Decoy Therapeutics Inc. in January 2026. Decoy Therapeutics Inc. is based in Houston, Texas.

Organisation	Decoy Therapeutics Inc.
Headquarters	2450 Holcombe Blvd, Houston, TX, United States, 77021
Industry	Biotechnology
CEO	Mr. Frederick E. Pierce II
E-voting on shares	Click here to vote

Key Management of Decoy Therapeutics Inc.

Name	Title
Mr. Frederick E. Pierce II	CEO & Director
Mr. Mark J. Rosenblum CPA	Executive VP of Finance & CFO
Dr. Barbara Hibner Ph.D.	Chief Scientific Officer
Mr. Peter K. Marschel M.B.A., M.S.	Chief Business Officer

FAQs

What is Decoy Therapeutics Inc. share price today?

Decoy Therapeutics Inc. share price today is $5.61 as on July 18, 2026 at 8:45 am IST at the close of the market. Decoy Therapeutics Inc. share today touched a day high of $6.06 and a low of $5.49.

What is the 52 week high and 52 week low for Decoy Therapeutics Inc. share?

Decoy Therapeutics Inc. share touched a 52 week high of $0.00 on January 1, 1970 and a 52 week low of $0.00 on January 1, 1970. Decoy Therapeutics Inc. stock price today i.e. July 18, 2026 at 8:45 am IST is closed at $5.61,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Decoy Therapeutics Inc.'s market capitalisation today?

Decoy Therapeutics Inc. market capitalisation is $0.00T as on July 18, 2026 at 8:45 am IST.

How to invest in Decoy Therapeutics Inc. Stock (DCOY) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Decoy Therapeutics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Decoy Therapeutics Inc. Shares that will get you 0.2674 shares as per Decoy Therapeutics Inc. share price of $5.61 per share as on July 18, 2026 at 8:45 am IST.

What is the minimum amount required to buy Decoy Therapeutics Inc. Stock (DCOY) from India?

Indian investors can start investing in Decoy Therapeutics Inc. (DCOY) shares with as little as ₹96.28 or $1 (as of July 18, 2026 at 7:40 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹962.80 in Decoy Therapeutics Inc. stock (as per the Rupee-Dollar exchange rate as on July 18, 2026 at 7:40 pm IST). Based on Decoy Therapeutics Inc. share’s latest price of $5.61 as on July 18, 2026 at 8:45 am IST, you will get 1.7825 shares of Decoy Therapeutics Inc.. Learn more about fractional shares .